Platelet factor XIII gene expression and embolic propensity in atrial fibrillation

Thrombosis and Haemostasis

Volumn 106, Issue 1, 2011, Pages 75-82

  Gosk Bierska, Izabella ^a,b   Mcbane, Robert D ^a   Wu, Yanhong ^a   Mruk, Jozef ^c,d   Tafur, Alfonso ^a   Mcleod, Thomas ^a   Wysokinski, Waldemar E ^a  

^a MAYO CLINIC   (United States)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^d Wichita Clinic   (United States)

Author keywords

References

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 13; GLYCOPROTEIN IB; HISTONE H2A; INTEGRIN; INTEGRIN ALPHA2BBETA3; PLATELET FACTOR XIII SUBUNIT A; THROMBOCYTE FACTOR; UNCLASSIFIED DRUG; WARFARIN;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EMBOLECTOMY; FEMALE; GENE EXPRESSION; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART LEFT ATRIUM; HEART SURGERY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NON VALVULAR ATRIAL FIBRILLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; RNA ANALYSIS; RNA EXTRACTION; THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; BLOOD PLATELETS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLECTOMY; EMBOLISM; FACTOR XIII; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; ORGAN SPECIFICITY; RNA, MESSENGER; THROMBOEMBOLISM;

EID: 79960068079     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-11-0765     Document Type: Article

References (55)

1. Aberg H. Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material. Acta Med Scand 1969; 185: 373-379.
2. Manning WJ, Silverman DI, Waksmonski CA, et al. Prevalence of residual left atrial thrombi among patients with acute thromboembolism and newly recognized atrial fibrillation. Arch Intern Med 1995; 155: 2193-2198.
3. Klein AL, Grimm RA, Murray RD, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation N Engl J Med 2001; 344: 1411-1420.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983-988.
5. Miller VT, Rothrock JF, Pearce LA, et al. Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Stroke Prevention in Atrial Fibrillation Investigators. Neurology 1993; 43: 32-36.
6. Hart RG, Pearce LA, Miller VT, et al. Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis 2000; 10: 39-43.
7. Wysokinski WE, Ammash N, Sobande F, et al. CHADS2 and echocardiographic predictors of left atrial thrombus in non-valvular atrial fibrillation. Am Heart J 2010; 159: 665-671.
8. Wysokinski WE, Owen WG, Fass DN, et al. Atrial Fibrillation and Thrombosis: Immunohistochemical Differences between In Situ and Embolized. J Thromb Haemost 2004; 2: 1637-1644
9. Thompson CB, Eaton KA, Princiotta SM, et al. Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity and function. Br J Haematol 1982; 50: 509-519.
10. Giles H, Smith REA, Martin JF. Platelet glycoprotein IIb/IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest 1994; 24: 69-72.
11. Bath P, Algert C, Chapman N, et al. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004; 35: 622-626.
12. Alberio LJ, Clemetson KJ. All platelets are not equal: COAT platelets. Curr Hematol Rep 2004; 3: 338-343.
13. Colkesen Y, Acil T, Abayli B, et al. Mean platelet volume is elevated during paroxysmal atrial fibrillation: a marker of increased platelet activation? Blood Coagul Fibrinolysis 2008; 19: 411-414.
14. Weyrich AS, Dixon DA, Pabla R, et al. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci USA 1998; 95: 5556-5561
15. Pabla R, Weyrich AS, Dixon DA, et al. Integrin-dependent control of translation: Engagement of integrin IIb 3 regulates synthesis of proteins in activated human platelets. J Cell Biol 1999; 144: 175-184.
16. Gnatenko DV, Dunn JJ, McCorkle SR, et al. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 2003; 101: 2285-2293.
17. McRedmond JP, Park SD, Reilly DF, et al. Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Mol Cell Proteomics 2004; 3: 133-144.
18. Schwabe H, Stein U, Walther W. High-copy cDNA amplification of minimal total RNA quantities for gene expression analysis. Mol Biotechnol 2000; 14: 165-172.
19. Rox JM, Bugert P, M·ler J, et al. Gene expression analysis in platelets from a single donor: evaluation of a PCR-based amplification technique. Clin Chem 2004; 50: 2271-2278.
20. Godfrey TE, Kim SH, Chavira M, et al. Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction. J Mol Diagn 2000; 2: 84-91.
21. Zhang F, Wang ZM, Liu HY, et al. Application of RT-PCR in formalin-fixed and paraffin-embedded lung cancer tissues. Acta Pharmacol Sin 2010; 31: 111-117.
22. Shim MH, Hoover A, Blake N, et al. Gene expression profile of primary human CD34+CD38lo cells differentiating along the megakaryocyte lineage. Exp Hematol 2004; 32: 638-648.
23. Morris TD, Weber LA, Hickey E, et al. Changes in the stability of a human H3 histone mRNA during the HeLa cell cycle. Mol Cell Biol 1991; 11: 544-553.
24. Harris ME, Bohni R, Schneiderman MH, et al. Regulation of histone mRNA in the unperturbed cell cycle: Evidence suggesting control at two posttranscriptional steps. Mol. Cell Biol 1991; 11: 2416-2424.
25. Greenberg CS, Sane DC, Lai T. In: Hemostasis and Thrombosis, 5th edn., Lippincott Williams and Wilkins: Philadelphia, 2006; pp.153-181.
26. Varga-Szabo D, Pleines I, Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 2008; 28: 403-412.
27. Luo SZ. Role of the transmembrane domain of glycoprotein IX in assembly of the glycoprotein Ib-IX complex. J Thromb Haemost 2007; 5: 2494-2502.
28. Preston RJ, Tran S, Johnson JA, et al. Platelet factor 4 impairs the anticoagulant activity of activated protein C. Biol Chem 2009; 284: 5869-5875.
29. Pruissen DM, Slooter AJ, Rosendaal FR, et al. Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke. Blood 2008; 111: 1282-1286.
30. Muszbek L, Yee VC, Hevessy Z. Blood coagulation factor XIII: structure and function. Thromb Res 1999; 94: 271-305.
31. Poon MC, Russel JA, Low S, et al. Hemopoietic origin of factor XIII subunits in platelets, monocytes and plasma. Evidence from bone marrow transplantation studies. J Clin Invest 1989; 84: 787-792.
32. Wöpl A, Lattke H., Board PG., et al. Coagulation factor XIII A and B subunits in bone marrow and liver transplantation. Transplantation 1987; 43:151-153.
33. Joist JH, Niewiarowski S. Retention of platelet fibrin stabilizing factor during the platelet release reaction and clot retraction. Thromb Diath Haemorrh 1973; 29: 679-683.
34. Adany R, Bardos H. Factor XIII subunit A as an intracellular transglutaminase. Cell Mol Life Sci 2003; 60: 1049-1060.
35. Kaetsu H, Hashiguchi T, Foster D, et al. Expression and release of the a and b subunits for human coagulation factor XIII in baby hamster kidney (BHK) cells. J Biochem 1996; 119: 961-969.
36. MacKenzie A, Wilson HL, Kiss-Toth E, et al. Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 2001; 15: 825-835.
37. Mignatti P, Morimoto T, Rifkin DB. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 1992; 151: 81-93.
38. Backhaus R, Zehe C, Wegehingel S, et al. Unconventional protein secretion: membrane translocation of FGF-2 does not require protein unfolding. J Cell Sci 2004; 117: 1727-1736.
39. Cordell PA, Kile BT, Standeven KF, et al. Association of coagulation factor XIII-A with Golgi proteins within monocyte-macrophages: implications for subcellular trafficking and secretion. Blood 2010; 115: 2674-2681.
40. Owen WG, Bichler J, Ericson D, et al. Gating of thrombin in platelet aggregates by pO2-linked lowering of extracellular Ca2+ concentration. Biochemistry 1995; 34: 9277-9281.
41. Jayo A, Conde I, Lastres P, et al. New insights into the expression and role of platelet factor XIII-A. J Thromb Haemost 2009; 7: 1184-1191.
42. Serrano K, Devine DV. Intracellular factor XIII crosslinks platelet cytoskeletal elements upon platelet activation. Thromb Haemost 2002; 88: 315-320.
43. Kasahara K, Souri M, Kaneda M, et al. Impaired clot retraction in factor XIIIA subunit-deficient mice. Blood 2010; 115: 1277-1279.
44. Cohen I, Glaser T, Veis A, et al. Ca2+dependent cross-linking processes in human platelets. Biochim Biophys Acta 1981; 676: 137-147.
45. Muszbek L, Polgár J, Boda Z. Platelet factor XIII becomes active without the release of activation peptide during platelet activation. Thromb Haemost 1993; 69: 282-285.
46. Hornyak TJ, Shafer JA. Role of calcium ion in the generation of factor XIII activity. Biochemistry 1991; 30: 6175-6182.
47. Ando Y, Imamura S, Yamagata Y, et al. Platelet factor XIII is activated by calpain. Biochem Biophys Res Commun 1987; 144: 484-490.
48. Dunois-Larde C, Capron C, Fichelson S, et al. Exposure of human megakaryocytes to high shear rates accelerates platelet production. Blood 2009; 114: 1875-1883
49. Prodan CI, Joseph PM, Vincent AS, et al. Coated-platelets in ischemic stroke: differences between lacunar and cortical stroke. J Thromb Haemost 2008; 6: 609-614.
50. Aksu H, Ozer O, Unal H, et al. Significance of mean platelet volume on prognosis of patients with and without aspirin resistance in settings of non-ST-segment elevated acute coronary syndromes. Blood Coagul Fibrinolysis 2009; 20: 686-693.
51. Wysokinski, WE., Konik E, McBane RD, et al. Left Atrial Stasis and VWFADAMTS 13 system in atrial fibrillation. J Am Coll Cardiol 2010; 55 (Suppl): Abstract 2505-439 - A213.
52. Li J, Smyth P, Flavin R, et al. Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol 2007; 7: 36.
53. Jarzab M, Róanowski P, Kowalska M, et al. Optimization of the method of RNA isolation from paraffin blocks to assess gene expression in breast cancer. Pol J Pathol 2008; 59: 85-91.
54. Bibikova M, Talantov D, Chudin E, et al. Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays. Am J Pathol 2004; 165: 1799-1807.
55. McBane RD, Hodge DO, Wysokinski WE. Clinical and echocardiographic measures governing thromboembolism destination in atrial fibrillation. Thromb Haemost. 2008; 99: 951-955.